Who Paid My Doc
Corevalve Evolut R
Device Transcatheter Valve Systems
PDI 00763000017651
General payments
$26,490,552
Research payments
$31,968,818
Through program year 2025, $26,490,552 in general payments and $31,968,818 in research payments were reported against Corevalve Evolut R (Transcatheter Valve Systems).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $5,638,934 | 28,609 |
| 2025 | Research | $9,551,788 | 1,984 |
| 2024 | General | $7,430,205 | 30,436 |
| 2024 | Research | $7,704,277 | 2,260 |
| 2023 | General | $7,181,144 | 30,474 |
| 2023 | Research | $6,927,823 | 1,861 |
| 2022 | General | $6,240,168 | 27,424 |
| 2022 | Research | $7,784,931 | 1,902 |
| 2021 | General | $101 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 91 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
116,944 general · 8,007 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.